Clinical Outcomes and Selection Criteria for Prodromal Huntington's Disease Trials
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical Outcomes and Selection Criteria for Prodromal Huntington's Disease Trials
Authors
Keywords
-
Journal
MOVEMENT DISORDERS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-07-20
DOI
10.1002/mds.28222
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Patient-reported impact of symptoms in Huntington disease
- (2020) Alistair M. Glidden et al. NEUROLOGY
- Association of CAG Repeats With Long-term Progression in Huntington Disease
- (2019) Douglas R. Langbehn et al. JAMA Neurology
- Cortical thickness, stance control, and arithmetic skill: An exploratory study in premanifest Huntington disease
- (2018) Lorenzo Nanetti et al. PARKINSONISM & RELATED DISORDERS
- Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study
- (2018) Ralf Reilmann et al. LANCET NEUROLOGY
- Therapies targeting DNA and RNA in Huntington's disease
- (2017) Edward J Wild et al. LANCET NEUROLOGY
- Design optimization for clinical trials in early-stage manifest Huntington's disease
- (2017) Chris Frost et al. MOVEMENT DISORDERS
- Motor, cognitive, and functional declines contribute to a single progressive factor in early HD
- (2017) Scott A. Schobel et al. NEUROLOGY
- Concise Review: The Use of Stem Cells for Understanding and Treating Huntington's Disease
- (2017) Bronwen Connor STEM CELLS
- Diminishing return for mechanistic therapeutics with neurodegenerative disease duration?
- (2016) David C. Rubinsztein et al. BIOESSAYS
- Current Pharmacological Approaches to Reduce Chorea in Huntington’s Disease
- (2016) Emma M. Coppen et al. DRUGS
- Validation of a prognostic index for Huntington's disease
- (2016) Jeffrey D. Long et al. MOVEMENT DISORDERS
- Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS)
- (2016) et al. JAMA Neurology
- Cognitive deficits predict poorer functional capacity in Huntington’s disease: But what is being measured?
- (2015) Clare M. Eddy et al. NEUROPSYCHOLOGY
- Prediction of manifest Huntington's disease with clinical and imaging measures: a prospective observational study
- (2014) Jane S Paulsen et al. LANCET NEUROLOGY
- Huntington disease: natural history, biomarkers and prospects for therapeutics
- (2014) Christopher A. Ross et al. Nature Reviews Neurology
- Clinical and Biomarker Changes in Premanifest Huntington Disease Show Trial Feasibility: A Decade of the PREDICT-HD Study
- (2014) Jane S. Paulsen et al. Frontiers in Aging Neuroscience
- Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data
- (2013) Sarah J Tabrizi et al. LANCET NEUROLOGY
- Characterization of a Large Group of Individuals with Huntington Disease and Their Relatives Enrolled in the COHORT Study
- (2012) E. Ray Dorsey et al. PLoS One
- Clinical impairment in premanifest and early Huntington's disease is associated with regionally specific atrophy
- (2011) Rachael I. Scahill et al. HUMAN BRAIN MAPPING
- Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data
- (2009) Sarah J Tabrizi et al. LANCET NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search